Convection-enhanced drug delivery for glioblastoma: A review

RS D'Amico, MK Aghi, MA Vogelbaum… - Journal of Neuro …, 2021 - Springer
Introduction Convection-enhanced delivery (CED) is a method of targeted, local drug
delivery to the central nervous system (CNS) that bypasses the blood-brain barrier (BBB) …

Prodrugs for improving tumor targetability and efficiency

R Mahato, W Tai, K Cheng - Advanced drug delivery reviews, 2011 - Elsevier
As the mainstay in the treatment of various cancers for several decades, chemotherapy is
successful but still faces challenges including non-selectivity and high toxicity. Improving the …

A phase III clinical evaluation of herpes simplex virus type 1 thymidine kinase and ganciclovir gene therapy as an adjuvant to surgical resection and radiation in adults …

NG Rainov - Human gene therapy, 2000 - liebertpub.com
Previous uncontrolled clinical trials have shown the in vivo retrovirus (RV)-mediated
transduction of glioblastoma cells with the herpes simplex virus thymidine kinase (HSV-tk) …

Convection-enhanced delivery in glioblastoma: a review of preclinical and clinical studies

A Jahangiri, AT Chin, PM Flanigan, R Chen… - Journal of …, 2017 - thejns.org
Glioblastoma is the most common malignant brain tumor, and it carries an extremely poor
prognosis. Attempts to develop targeted therapies have been hindered because the blood …

Progress in gene therapy for neurological disorders

M Simonato, J Bennett, NM Boulis, MG Castro… - Nature Reviews …, 2013 - nature.com
Diseases of the nervous system have devastating effects and are widely distributed among
the population, being especially prevalent in the elderly. These diseases are often caused …

Convection-enhanced delivery of nanocarriers for the treatment of brain tumors

E Allard, C Passirani, JP Benoit - Biomaterials, 2009 - Elsevier
Primary brain tumors have a significant infiltrative capacity as their reappearance after
resection usually occurs within 2cm of the tumor margin. Local delivery method such as …

Targeted delivery of antitumoral therapy to glioma and other malignancies with synthetic chlorotoxin (TM-601)

AN Mamelak, DB Jacoby - Expert opinion on drug delivery, 2007 - Taylor & Francis
Targeted therapies for cancer is a rapidly advancing field, but the identification of tumor-
specific ligands has proven difficult. Chlorotoxin (CTX) is a small, 36 amino acid neurotoxin …

Viral gene therapy strategies: from basic science to clinical application

LS Young, PF Searle, D Onion… - The Journal of …, 2006 - Wiley Online Library
A major impediment to the successful application of gene therapy for the treatment of a
range of diseases is not a paucity of therapeutic genes, but the lack of an efficient non‐toxic …

AdvHSV-tk gene therapy with intravenous ganciclovir improves survival in human malignant glioma: a randomised, controlled study

A Immonen, M Vapalahti, K Tyynelä, H Hurskainen… - Molecular therapy, 2004 - cell.com
Malignant glioma is a devastating brain tumor with no effective treatment. This randomised,
controlled study involved 36 patients with operable primary or recurrent malignant glioma …

Selective ablation of human embryonic stem cells expressing a “suicide” gene

M Schuldiner, J Itskovitz-Eldor, N Benvenisty - Stem cells, 2003 - academic.oup.com
Over the past few years, technological procedures have been developed for utilizing stem
cells in transplantation medicine. Human embryonic stem (ES) cells can produce an …